226 related articles for article (PubMed ID: 26616677)
1. Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.
Tarin C; Carril M; Martin-Ventura JL; Markuerkiaga I; Padro D; Llamas-Granda P; Moreno JA; García I; Genicio N; Plaza-Garcia S; Blanco-Colio LM; Penades S; Egido J
Sci Rep; 2015 Nov; 5():17135. PubMed ID: 26616677
[TBL] [Abstract][Full Text] [Related]
2. CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles.
Rubio-Navarro A; Carril M; Padro D; Guerrero-Hue M; Tarín C; Samaniego R; Cannata P; Cano A; Villalobos JM; Sevillano ÁM; Yuste C; Gutiérrez E; Praga M; Egido J; Moreno JA
Theranostics; 2016; 6(6):896-914. PubMed ID: 27162559
[TBL] [Abstract][Full Text] [Related]
3. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
[TBL] [Abstract][Full Text] [Related]
4. CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques.
Bengtsson E; Hultman K; Edsfeldt A; Persson A; Nitulescu M; Nilsson J; Gonçalves I; Björkbacka H
Sci Rep; 2020 Sep; 10(1):14362. PubMed ID: 32873809
[TBL] [Abstract][Full Text] [Related]
5. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
[TBL] [Abstract][Full Text] [Related]
6. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
7. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
8. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
[TBL] [Abstract][Full Text] [Related]
9. Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis.
Zhang X; Heo GS; Li A; Lahad D; Detering L; Tao J; Gao X; Zhang X; Luehmann H; Sultan D; Lou L; Venkatesan R; Li R; Zheng J; Amrute J; Lin CY; Kopecky BJ; Gropler RJ; Bredemeyer A; Lavine K; Liu Y
J Nucl Med; 2024 May; 65(5):775-780. PubMed ID: 38548349
[TBL] [Abstract][Full Text] [Related]
10. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
11. CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.
Guo L; Akahori H; Harari E; Smith SL; Polavarapu R; Karmali V; Otsuka F; Gannon RL; Braumann RE; Dickinson MH; Gupta A; Jenkins AL; Lipinski MJ; Kim J; Chhour P; de Vries PS; Jinnouchi H; Kutys R; Mori H; Kutyna MD; Torii S; Sakamoto A; Choi CU; Cheng Q; Grove ML; Sawan MA; Zhang Y; Cao Y; Kolodgie FD; Cormode DP; Arking DE; Boerwinkle E; Morrison AC; Erdmann J; Sotoodehnia N; Virmani R; Finn AV
J Clin Invest; 2018 Mar; 128(3):1106-1124. PubMed ID: 29457790
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of hemoglobin scavenger receptor CD163 in accumulated macrophages within filtered debris between acute coronary syndromes and stable angina pectoris.
Sato T; Kameyama T; Noto T; Ueno H; Inoue H
Int Heart J; 2015; 56(2):150-6. PubMed ID: 25740391
[TBL] [Abstract][Full Text] [Related]
13. Association between hemoglobin scavenger receptor and heme oxygenase-1-related anti-inflammatory mediators in human coronary stable and unstable plaques.
Yunoki K; Inoue T; Sugioka K; Nakagawa M; Inaba M; Wada S; Ohsawa M; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M; Naruko T
Hum Pathol; 2013 Oct; 44(10):2256-65. PubMed ID: 23850497
[TBL] [Abstract][Full Text] [Related]
14. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
15. Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques.
Hultman K; Edsfeldt A; Björkbacka H; Dunér P; Sundius L; Nitulescu M; Persson A; Boyle JJ; Nilsson J; Hultgårdh-Nilsson A; Bengtsson E; Gonçalves I
Stroke; 2019 Nov; 50(11):3289-3292. PubMed ID: 31495329
[TBL] [Abstract][Full Text] [Related]
16. Identifying macrophage enrichment in atherosclerotic plaques by targeting dual-modal US imaging/MRI based on biodegradable Fe-doped hollow silica nanospheres conjugated with anti-CD68 antibody.
Ji R; Li X; Zhou C; Tian Q; Li C; Xia S; Wang R; Feng Y; Zhan W
Nanoscale; 2018 Nov; 10(43):20246-20255. PubMed ID: 30361722
[TBL] [Abstract][Full Text] [Related]
17. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.
Gleissner CA; Shaked I; Erbel C; Böckler D; Katus HA; Ley K
Circ Res; 2010 Jan; 106(1):203-11. PubMed ID: 19910578
[TBL] [Abstract][Full Text] [Related]
18. The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.
Moreno JA; Muñoz-García B; Martín-Ventura JL; Madrigal-Matute J; Orbe J; Páramo JA; Ortega L; Egido J; Blanco-Colio LM
Atherosclerosis; 2009 Nov; 207(1):103-10. PubMed ID: 19473660
[TBL] [Abstract][Full Text] [Related]
19. Impaired macrophage production of anti-atherosclerotic interleukin-10 induced by coronary intraplaque hemorrhage in patients with acute coronary syndrome and hyperglycemia.
Sato T; Kameyama T; Noto T; Inoue H
J Diabetes Complications; 2014; 28(2):196-202. PubMed ID: 24239333
[TBL] [Abstract][Full Text] [Related]
20. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin.
Schaer CA; Schoedon G; Imhof A; Kurrer MO; Schaer DJ
Circ Res; 2006 Oct; 99(9):943-50. PubMed ID: 17008602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
